Research track Neuroscience
Quick links to research tracks
| Cancer | Cardiovascular diseases | Chemical Biology |
| Drug development | Infection | Inflammation |
| Lung function | Metabolism | Neuroscience |
| Reproduction and development | Musculoskeletal system |
Next event
The next track event will be on 10 January, 2023, at BMC 15:00–18:00.
About the research track
This research track has a focus on clinical and pre-clinical aspects of neurological disorders, syndroms and mechanisms.
Workshop 10 January
When: 10 January 15:00–17:00
Where: BMC A1:111a
Gary L. Wenk
“Preventing Brain Aging via the Diet” – discusses the role of inflammation in aging, asks and answers the question of why we age and how diet and drugs can slow the cognitive consequences of aging.
Gary L. Wenk, a Professor of Psychology & Neuroscience at the Ohio State University, is a leading authority on the consequences of chronic brain inflammation and animal models of Alzheimer's disease. He received a Ph.D. in Neurotoxicology from the University of Cincinnati and then trained as a post-doctoral fellow in the laboratory of two pioneers of Alzheimer research: Drs. Peter Davies and Robert Terry at the Albert Einstein College of Medicine.
He then joined the faculty of the Departments of Psychology and Pathology at the Johns Hopkins University for nine years and served as a Program Director for the Neurobiology of Learning and Memory & Biological Basis of Behavior Program, Division of Behavioral and Neural Sciences, at the National Science Foundation. He joined the faculty of the University of Arizona and was a research scientist in the Division of Neural Systems, Memory & Aging for 15 years.
Professor Wenk has had continuous RO1-level support from the National Institutes of Health since 1984 and has served as chairperson of three different NIH study sections since 1997. Professor Wenk was elected in 2008 to the rank of Fellow by the American Association for the Advancement of Science for distinguished contributions in the field of neuropharmacology, neurodegenerative diseases and neuroinflammatory processes. This rank was first given in 1874 to members of AAAS whose “efforts on behalf of the advancement of science or its applications are scientifically or socially distinguished”.
Stina Syvänen
“Positron emission tomography (PET) imaging in Alzheimer’s disease – past, present and future from an Uppsala perspective”
Stina Syvänen, a Professor of Molecular Geriatrics at Uppsala University has worked with PET imaging of the brain with a focus on neurodegeneration and drug delivery to the brain. She received a Ph.D. in Pharmacokinetics at the Faculty of Pharmacy at Uppsala University in 2008 before moving to Leiden University for a post doc within a large EU-funded research consortium aiming to develop PET diagnostics for Alzheimer’s disease and epilepsy.
Since 2012 she has continued her research at the Medical Faculty at Uppsala University pioneering work on “antibody-based PET imaging”. Stina will discuss the role of positron emission tomography (PET) in Alzheimer’s disease, and give a historical perspective on the role of Uppsala in the development of PET diagnostics in this field.
Kick-off at Gimo Herrgård
The research track had a successful kick-off at Gimo Herrgård on 20-21 October. The PhD students made many suggestions for future activities. “This meeting was both productive and of great importance,” said track leader Åsa Konradsson-Geuken.
Research Track Neuroscience preparing for increased collaboration
Trackleaders: Åsa Konradsson Geuken och Stina Syvänen